Amedeo Smart

Free Medical Literature Service


 

Amedeo

Vaccines

  Free Subscription

Articles published in
BMJ
    September 2022
  1. IACOBUCCI G
    UK childhood vaccination rates fell last year in almost all programmes, figures show.
    BMJ. 2022;378:o2353.
    >> Share

  2. MAJEED A, Pollock K, Hodes S, Papaluca M, et al
    Implementation of covid-19 vaccination in the United Kingdom.
    BMJ. 2022;378:e070344.
    >> Share

  3. TAYLOR L
    Covid-19: PAHO calls for Americas to reverse vaccination setbacks caused by pandemic.
    BMJ. 2022;378:o2344.
    >> Share

  4. MAHASE E
    Parents are urged to vaccinate 2-3 year olds against flu as NHS warns of "twindemic".
    BMJ. 2022;378:o2335.
    >> Share

  5. THIAGARAJAN K
    Why did rabies control fail in India?
    BMJ. 2022;378:o2284.
    >> Share

    August 2022
  6. MAHASE E
    Monkeypox: Fractional vaccine doses will be piloted as new treatment trial launches.
    BMJ. 2022;378:o2080.
    >> Share

  7. COX D
    What do we know about covid-19 vaccines in under 5s?
    BMJ. 2022;378:o1892.
    >> Share

  8. WISE J
    Monkeypox: UK to run out of vaccine doses by next week.
    BMJ. 2022;378:o2053.
    >> Share

  9. MAHASE E
    Covid-19: UK will roll out Moderna's omicron BA.1 vaccine as part of autumn booster programme.
    BMJ. 2022;378:o2038.
    >> Share

  10. FELL DB, Dimanlig-Cruz S, Regan AK, Haberg SE, et al
    Risk of preterm birth, small for gestational age at birth, and stillbirth after covid-19 vaccination during pregnancy: population based retrospective cohort study.
    BMJ. 2022;378:e071416.
    >> Share

  11. WISE J
    Covid-19: Study provides further evidence that mRNA vaccines are safe in pregnancy.
    BMJ. 2022;378:o2013.
    >> Share

  12. HUSSAIN Z
    Polio vaccine is offered to all children in London aged 1 to 9 after virus detected in sewage.
    BMJ. 2022;378:o2007.
    >> Share

  13. BADELL ML, Dude CM, Rasmussen SA, Jamieson DJ, et al
    Covid-19 vaccination in pregnancy.
    BMJ. 2022;378:e069741.
    >> Share

  14. TAYLOR L
    Monkeypox: Concerns mount over vaccine inequity.
    BMJ. 2022;378:o1971.
    >> Share

  15. KECHAGIAS KS, Kalliala I, Bowden SJ, Athanasiou A, et al
    Role of human papillomavirus (HPV) vaccination on HPV infection and recurrence of HPV related disease after local surgical treatment: systematic review and meta-analysis.
    BMJ. 2022;378:e070135.
    >> Share

    July 2022
  16. SAXENA S, Skirrow H, Wighton K
    Vaccinating children aged under 5 years against covid-19.
    BMJ. 2022;378:o1863.
    >> Share

  17. HORNE EMF, Hulme WJ, Keogh RH, Palmer TM, et al
    Waning effectiveness of BNT162b2 and ChAdOx1 covid-19 vaccines over six months since second dose: OpenSAFELY cohort study using linked electronic health records.
    BMJ. 2022;378:e071249.
    >> Share

  18. POPLE D, Monk EJM, Evans S, Foulkes S, et al
    Burden of SARS-CoV-2 infection in healthcare workers during second wave in England and impact of vaccines: prospective multicentre cohort study (SIREN) and mathematical model.
    BMJ. 2022;378:e070379.
    >> Share

  19. BREATHNACH AS
    Rapid covid-19 vaccination for health workers.
    BMJ. 2022;378:o1674.
    >> Share

  20. HULME WJ, Williamson EJ, Green ACA, Bhaskaran K, et al
    Comparative effectiveness of ChAdOx1 versus BNT162b2 covid-19 vaccines in health and social care workers in England: cohort study using OpenSAFELY.
    BMJ. 2022;378:e068946.
    >> Share

  21. ANDERSSON NW, Thiesson EM, Laursen MV, Mogensen SH, et al
    Safety of heterologous primary and booster schedules with ChAdOx1-S and BNT162b2 or mRNA-1273 vaccines: nationwide cohort study.
    BMJ. 2022;378:e070483.
    >> Share

  22. REZA HM, Agarwal V, Sultana F, Bari R, et al
    Why are vaccination rates lower in low and middle income countries, and what can we do about it?
    BMJ. 2022;378:e069506.
    >> Share

  23. WISE J
    Covid-19: MPs call for greater efforts to reach the unvaccinated and partially vaccinated.
    BMJ. 2022;378:o1743.
    >> Share

  24. PILLAY J, Gaudet L, Wingert A, Bialy L, et al
    Incidence, risk factors, natural history, and hypothesised mechanisms of myocarditis and pericarditis following covid-19 vaccination: living evidence syntheses and review.
    BMJ. 2022;378:e069445.
    >> Share

  25. BLOCK J
    Covid-19: Researchers face wait for patient level data from Pfizer and Moderna vaccine trials.
    BMJ. 2022;378:o1731.
    >> Share

  26. DYER O
    Covid vaccines: Canada to dispose of 13.6 million AstraZeneca doses owing to lack of demand.
    BMJ. 2022;378:o1700.
    >> Share

  27. GREWAL R, Kitchen SA, Nguyen L, Buchan SA, et al
    Effectiveness of a fourth dose of covid-19 mRNA vaccine against the omicron variant among long term care residents in Ontario, Canada: test negative design study.
    BMJ. 2022;378:e071502.
    >> Share

  28. WILKINSON E
    Covid-19: GPs are asked to opt into next vaccination phase this autumn.
    BMJ. 2022;378:o1657.
    >> Share

  29. SAUL H, Gursul D, Antonelli M, Steves C, et al
    Frail older people and those in deprived areas remain at risk from covid-19, even after vaccination.
    BMJ. 2022;378:o1313.
    >> Share

    June 2022
  30. CLARKE E, Kampmann B
    No one is safe until everyone is safe-from polio too.
    BMJ. 2022;377:o1625.
    >> Share

  31. MAHASE E
    Polio: What do we know about the polioviruses detected in the UK?
    BMJ. 2022;377:o1578.
    >> Share

  32. WISE J
    Covid-19: UK makes first payments to compensate injury or death from vaccines.
    BMJ. 2022;377:o1565.
    >> Share

  33. WISE J
    Moderna to open mRNA vaccine research and manufacturing centre in the UK.
    BMJ. 2022;377:o1556.
    >> Share

  34. MAHASE E
    Monkeypox: Gay and bisexual men with high exposure risk will be offered vaccine in England.
    BMJ. 2022;377:o1542.
    >> Share

  35. TANNE JH
    Covid-19: CDC and FDA approve Pfizer and Moderna vaccines for under 5s.
    BMJ. 2022;377:o1507.
    >> Share

  36. SAXENA S, Skirrow H, Maini A, Hayhoe B, et al
    Consenting children aged under 18 for vaccination and treatment.
    BMJ. 2022;377:e068889.
    >> Share

  37. HITCHINGS MDT, Ranzani OT, Lind ML, Dorion M, et al
    Change in covid-19 risk over time following vaccination with CoronaVac: test negative case-control study.
    BMJ. 2022;377:e070102.
    >> Share

  38. MAZZILLI S, Moazen B, Stover H, Plugge E, et al
    Covid-19 vaccine in prison: a not-to-be-missed opportunity to promote access to vaccination in adolescents.
    BMJ. 2022;377:o1439.
    >> Share

  39. STOKEL-WALKER C
    How are vaccines being adapted to meet the changing face of SARS-CoV-2?
    BMJ. 2022;377:o1257.
    >> Share

  40. MAHASE E
    Monkeypox: Healthcare workers will be offered smallpox vaccine as UK buys 20 000 doses.
    BMJ. 2022;377:o1379.
    >> Share

    May 2022
  41. AU WY, Cheung PP
    Effectiveness of heterologous and homologous covid-19 vaccine regimens: living systematic review with network meta-analysis.
    BMJ. 2022;377:e069989.
    >> Share

  42. BRYCE E, Ong S
    Covid-19 and mRNA technology are helping Africa fix its vaccine problems.
    BMJ. 2022;377:o1196.
    >> Share

  43. WISE J
    Covid-19: Vaccine effectiveness wanes more rapidly for cancer patients, study finds.
    BMJ. 2022;377:o1305.
    >> Share

  44. GAZIT S, Saciuk Y, Perez G, Peretz A, et al
    Short term, relative effectiveness of four doses versus three doses of BNT162b2 vaccine in people aged 60 years and older in Israel: retrospective, test negative, case-control study.
    BMJ. 2022;377:e071113.
    >> Share

  45. HORDIJK L, Patnaik P
    Covid-19-How Europe's vaccine donations went tragically wrong.
    BMJ. 2022;377:o1286.
    >> Share

  46. WISE J
    NICE publishes guidance to increase uptake of routine vaccinations.
    BMJ. 2022;377:o1260.
    >> Share

  47. SIVAN M, Greenhalgh T, Milne R, Delaney B, et al
    Are vaccines a potential treatment for long covid?
    BMJ. 2022;377:o988.
    >> Share

  48. HOANG U, de Lusignan S, Joy M, Sherlock J, et al
    Future reporting of vaccine uptake needs to include any change in ethnic or socioeconomic disparities.
    BMJ. 2022;377:o1233.
    >> Share

  49. AYOUBKHANI D, Bermingham C, Pouwels KB, Glickman M, et al
    Trajectory of long covid symptoms after covid-19 vaccination: community based cohort study.
    BMJ. 2022;377:e069676.
    >> Share

  50. IACOBUCCI G
    Covid-19: Fourth dose of mRNA vaccines is safe and boosts immunity, study finds.
    BMJ. 2022;377:o1170.
    >> Share

  51. KWAN R
    How Hong Kong's vaccination missteps led to the world's highest covid-19 death rate.
    BMJ. 2022;377:o1127.
    >> Share

  52. MAHASE E
    Sixty seconds on . . . nasal vaccines.
    BMJ. 2022;377:o1148.
    >> Share

  53. MAHASE E
    Hepatitis: Ukrainian refugees should be offered vaccines and free treatment, says WHO.
    BMJ. 2022;377:o1132.
    >> Share

  54. USTIANOWSKI A
    Why covid vaccine studies are still needed.
    BMJ. 2022;377:o1135.
    >> Share

    April 2022
  55. BERDZULI N, Datta SS
    How to tackle inequitable access, vaccine hesitancy, and other barriers to achieve high vaccine uptake.
    BMJ. 2022;377:o1094.
    >> Share

  56. WISE J
    Covid-19: Drug companies urged to share vaccine technology to boost equity and access.
    BMJ. 2022;377:o1086.
    >> Share


  57. Covid-19: Is the US compensation scheme for vaccine injuries fit for purpose?
    BMJ. 2022;377:o1073.
    >> Share

  58. SUTHAR AB, Wang J, Seffren V, Wiegand RE, et al
    Public health impact of covid-19 vaccines in the US: observational study.
    BMJ. 2022;377:e069317.
    >> Share

  59. DYE C
    The benefits of large scale covid-19 vaccination.
    BMJ. 2022;377:o867.
    >> Share

  60. LOOI MK
    The BMJ Interview: WHO chief scientist optimistic for a pan-coronavirus vaccine in two years.
    BMJ. 2022;377:o1003.
    >> Share

  61. MAHASE E
    Covid-19: Mix and match booster vaccination approach offers best protection, study reports.
    BMJ. 2022;377:o1052.
    >> Share

  62. DEMASI M
    Covid-19: Is the US compensation scheme for vaccine injuries fit for purpose?
    BMJ. 2022;377:o919.
    >> Share

  63. MAHASE E
    Meningitis vaccine could protect against gonorrhoea, studies find.
    BMJ. 2022;377:o997.
    >> Share

  64. MAHASE E
    Covid-19: UK approves Valneva vaccine for adults under 50.
    BMJ. 2022;377:o985.
    >> Share

  65. MA A, Parry J
    When Hong Kong's "dynamic zero" covid-19 strategy met omicron, low vaccination rates sent deaths soaring.
    BMJ. 2022;377:o980.
    >> Share

  66. WILLICOMBE M, Scanlon M, Loud F, Lightstone L, et al
    Should we be clinically assessing antibody responses to covid vaccines in immunocompromised people?
    BMJ. 2022;377:o966.
    >> Share

  67. KILDEGAARD H, Lund LC, Hojlund M, Stensballe LG, et al
    Risk of adverse events after covid-19 in Danish children and adolescents and effectiveness of BNT162b2 in adolescents: cohort study.
    BMJ. 2022;377:e068898.
    >> Share

  68. TSAGKARIS C, Laubscher L, Vladychuk V
    Vaccine wastage as collateral damage in Ukrainian conflict.
    BMJ. 2022;377:o911.
    >> Share

  69. BINAGWAHO A, Mathewos K
    Rwanda's success in rolling out its covid-19 vaccination campaign is a lesson to us all.
    BMJ. 2022;377:o881.
    >> Share

    March 2022
  70. LOOI MK
    Disincentives for vaccine refusal.
    BMJ. 2022;376:o865.
    >> Share

  71. SMITH MA, Sherrah M, Sultana F, Castle PE, et al
    National experience in the first two years of primary human papillomavirus (HPV) cervical screening in an HPV vaccinated population in Australia: observational study.
    BMJ. 2022;376:e068582.
    >> Share

  72. MAJEED A, Tessier E, Stowe J, Mokdad AH, et al
    How data from the United Kingdom has guided covid-19 vaccine policies.
    BMJ. 2022;376:o839.
    >> Share

  73. KAMAL-YANNI M, Cueni T
    Should covid-19 vaccines and drugs be "not for profit"?
    BMJ. 2022;376:o755.
    >> Share

  74. HOWARD S, Krishna G
    The world's refugees remain last in line for covid-19 vaccines.
    BMJ. 2022;376:o703.
    >> Share

  75. DYER O
    Covid-19: WHO set to reject Canadian plant based vaccine because of links with tobacco industry.
    BMJ. 2022;376:o811.
    >> Share

  76. HATALA A, Pervaiz MC, Handley R, Vijayan T, et al
    Faith based dialogue can tackle vaccine hesitancy and build trust.
    BMJ. 2022;376:o823.
    >> Share


  77. It is not too late to achieve global covid-19 vaccine equity.
    BMJ. 2022;376:o812.
    >> Share

  78. TANNE JH
    Covid-19: Moderna will ask for authorisation for vaccine for infants and children.
    BMJ. 2022;376:o798.
    >> Share

  79. BERKLEY S
    Ending the covid-19 pandemic means helping countries to catch-up with vaccination, not giving up.
    BMJ. 2022;376:o786.
    >> Share

  80. YAMEY G, Garcia P, Hassan F, Mao W, et al
    It is not too late to achieve global covid-19 vaccine equity.
    BMJ. 2022;376:e070650.
    >> Share

  81. GUEST JL
    The US shouldn't settle for its current number of covid deaths or vaccination rates.
    BMJ. 2022;376:o763.
    >> Share

  82. TANNE JH
    Covid-19: Pfizer asks US regulator to authorise fourth vaccine dose for over 65s.
    BMJ. 2022;376:o711.
    >> Share

  83. WILKINSON E
    Covid-19: Doctors urge government to step up on global vaccine funding.
    BMJ. 2022;376:o709.
    >> Share

  84. LI X, Raventos B, Roel E, Pistillo A, et al
    Association between covid-19 vaccination, SARS-CoV-2 infection, and risk of immune mediated neurological events: population based cohort and self-controlled case series analysis.
    BMJ. 2022;376:e068373.
    >> Share

  85. POTTEGARD A, Klungel OH
    The neurological safety of covid-19 vaccines.
    BMJ. 2022;376:o522.
    >> Share

  86. TINARI S
    Covid-19: Ukraine conflict calls Russia's vaccine diplomacy into question.
    BMJ. 2022;376:o626.
    >> Share

  87. LAURING AS, Tenforde MW, Chappell JD, Gaglani M, et al
    Clinical severity of, and effectiveness of mRNA vaccines against, covid-19 from omicron, delta, and alpha SARS-CoV-2 variants in the United States: prospective observational study.
    BMJ. 2022;376:e069761.
    >> Share

  88. MAHASE E
    Covid-19: Coalition pledges $42m to develop broad protection vaccine against betacoronaviruses.
    BMJ. 2022;376:o628.
    >> Share

  89. DYER O
    Covid-19: Florida surgeon general says state will be first not to recommend vaccination for children.
    BMJ. 2022;376:o622.
    >> Share

  90. MAHASE E
    Covid-19: Public vaccine funding needs "strings attached" for equitable access, say campaigners.
    BMJ. 2022;376:o565.
    >> Share

  91. LEE ARYB, Wong SY, Chai LYA, Lee SC, et al
    Efficacy of covid-19 vaccines in immunocompromised patients: systematic review and meta-analysis.
    BMJ. 2022;376:e068632.
    >> Share

    February 2022
  92. TAYLOR L
    Covid-19: Lagging vaccination leaves the Caribbean vulnerable, says PAHO.
    BMJ. 2022;376:o519.
    >> Share

  93. MAHASE E
    Covid-19: Sanofi and GSK to seek regulatory authorisation for protein based vaccine.
    BMJ. 2022;376:o526.
    >> Share

  94. IACOBUCCI G
    Covid-19: Vaccine programme a success, but staff burnout is a major risk, auditors warn.
    BMJ. 2022;376:o493.
    >> Share

  95. WIESELER B
    Covid-19 vaccines: individual patient data should be submitted to the European Medicines Agency.
    BMJ. 2022;376:o417.
    >> Share

  96. GLOVER RE, Roberts AP, Singer AC, Kirchhelle C, et al
    Sale of UK's Vaccine Manufacturing and Innovation Centre.
    BMJ. 2022;376:e069999.
    >> Share

  97. ENNOS RA
    Covid-19 vaccines: we need immediate release of anonymised data from yellow card scheme.
    BMJ. 2022;376:o414.
    >> Share

  98. IACOBUCCI G
    Covid-19: Antibodies after AstraZeneca and Pfizer vaccines decrease with age and are higher in women, data show.
    BMJ. 2022;376:o428.
    >> Share

  99. LOPES H, McCallum A, Martin-Moreno JM, Middleton J, et al
    Invest in primary healthcare and public health for the pandemic and beyond.
    BMJ. 2022;376:o425.
    >> Share

  100. WISE J
    Covid-19: Vaccine will be offered to 5-11 year olds in England, Wales, and Scotland.
    BMJ. 2022;376:o411.
    >> Share

  101. MAHASE E
    Covid-19: Vaccinated people are less likely to get long covid, review finds.
    BMJ. 2022;376:o407.
    >> Share

  102. MAHASE E
    Covid-19: Solely refusing vaccine will not trigger a fitness to practise investigation, says GMC.
    BMJ. 2022;376:o372.
    >> Share

  103. LOSEVA P
    Data and distrust hamper Russia's vaccination programme.
    BMJ. 2022;376:o321.
    >> Share

  104. WILKINSON E
    Is anti-vaccine sentiment affecting routine childhood immunisations?
    BMJ. 2022;376:o360.
    >> Share

  105. FABIANI M, Puopolo M, Morciano C, Spuri M, et al
    Effectiveness of mRNA vaccines and waning of protection against SARS-CoV-2 infection and severe covid-19 during predominant circulation of the delta variant in Italy: retrospective cohort study.
    BMJ. 2022;376:e069052.
    >> Share

  106. MCKEE M, van Schalkwyk MCI
    England's U turn on covid-19 vaccine mandate for NHS staff.
    BMJ. 2022;376:o353.
    >> Share

  107. DAVIES M
    Covid-19: WHO efforts to bring vaccine manufacturing to Africa are undermined by the drug industry, documents show.
    BMJ. 2022;376:o304.
    >> Share

  108. IACOBUCCI G
    Covid-19: Medical regulators should ensure that health workers are vaccinated, says Javid.
    BMJ. 2022;376:o346.
    >> Share

  109. HODES S, Stanley S, Majeed A
    A national vaccination service for the NHS in England: a proposal to be considered with caution.
    BMJ. 2022;376:o338.
    >> Share

  110. ARONSON JK
    When I use a word . . . . Vaccination-rights and duties.
    BMJ. 2022;376:o317.
    >> Share

  111. STOKEL-WALKER C
    What do we know about covid vaccines and preventing transmission?
    BMJ. 2022;376:o298.
    >> Share

  112. WISE J
    Covid-19: UK approves Novavax's protein based vaccine.
    BMJ. 2022;376:o309.
    >> Share

  113. DYER C
    Covid-19: Vulnerable adult must be vaccinated against parents' wishes, judge rules.
    BMJ. 2022;376:o308.
    >> Share

  114. THORNTON J
    Covid-19: Trust in government and other people linked with lower infection rate and higher vaccination uptake.
    BMJ. 2022;376:o292.
    >> Share

  115. IACOBUCCI G
    Covid-19: Government abandons mandatory vaccination of NHS staff.
    BMJ. 2022;376:o269.
    >> Share

    January 2022
  116. HAWKSBEE L, McKee M, King L
    Don't worry about the drug industry's profits when considering a waiver on covid-19 intellectual property rights.
    BMJ. 2022;376:e067367.
    >> Share

  117. KMIETOWICZ Z
    Covid-19: Halt mandatory vaccination to keep England's maternity services safe, pleads royal college.
    BMJ. 2022;376:o249.
    >> Share

  118. TORJESEN I
    Covid-19: Lower vaccination rates partly explain higher death rates among minority ethnic groups.
    BMJ. 2022;376:o233.
    >> Share

  119. FREER J, Mudaly V
    HIV and covid-19 in South Africa.
    BMJ. 2022;376:e069807.
    >> Share

  120. FIALEK B
    On the verge of Poland's fifth wave of covid-19, healthcare staff are overworked and disenchanted.
    BMJ. 2022;376:o234.
    >> Share

  121. TAYLOR L
    Covid-19: Cuba will request WHO approval for homegrown vaccine.
    BMJ. 2022;376:o230.
    >> Share

  122. MALE V
    Menstruation and covid-19 vaccination.
    BMJ. 2022;376:o142.
    >> Share

  123. TAYLOR L
    Covid-19: CoronaVac immunity is strongest after boosting with a different vaccine.
    BMJ. 2022;376:o210.
    >> Share

  124. SOKOL D
    Why mandatory vaccination for healthcare workers should not be scrapped.
    BMJ. 2022;376:o206.
    >> Share

  125. IACOBUCCI G
    Covid-19: How prepared is England's NHS for mandatory vaccination?
    BMJ. 2022;376:o192.
    >> Share


  126. Covid-19 vaccines and treatments: we must have raw data, now.
    BMJ. 2022;376:o189.
    >> Share

  127. DOSHI P, Godlee F, Abbasi K
    Covid-19 vaccines and treatments: we must have raw data, now.
    BMJ. 2022;376:o102.
    >> Share

  128. WATERS A
    Covid-19: Reassess effects of mandatory vaccination on staffing, urge unions.
    BMJ. 2022;376:o139.
    >> Share

  129. IACOBUCCI G
    Covid-19: Focus should be on new vaccines rather than boosters, says WHO.
    BMJ. 2022;376:o108.
    >> Share

  130. DYER O
    Covid-19: Quebec to tax the unvaccinated as vaccine mandates spread in Europe.
    BMJ. 2022;376:o112.
    >> Share

  131. GOH S
    Valneva could appeal to the vaccine hesitant and may be more effective for longer.
    BMJ. 2022;376:o48.
    >> Share

  132. TANNE JH
    Covid-19: Vaccination during pregnancy is safe, finds large US study.
    BMJ. 2022;376:o27.
    >> Share

  133. PULLA P
    How covid-19 vaccines exposed India's adverse events reporting system.
    BMJ. 2022;376:n3146.
    >> Share

  134. IACOBUCCI G
    Covid-19: Fourth vaccine doses-who needs them and why?
    BMJ. 2022;376:o30.
    >> Share

  135. CHEBLY KO
    Centring equity over exceptionalism in the global covid-19 response.
    BMJ. 2022;376:o20.
    >> Share

  136. SHEPHERD A
    Vaccines wasted as Africa waits.
    BMJ. 2022;376:n3163.
    >> Share


  137. Covid-19: An urgent call for global "vaccines-plus" action.
    BMJ. 2022;376:o1.
    >> Share

    December 2021

  138. I am struggling to understand why patients decide not to get the covid vaccine.
    BMJ. 2021;375:n3152.
    >> Share

  139. PRUGGER C, Spelsberg A, Keil U, Erviti J, et al
    Evaluating covid-19 vaccine efficacy and safety in the post-authorisation phase.
    BMJ. 2021;375:e067570.
    >> Share

  140. PAGEL C, Squires A
    Schools: still a gaping hole in the English covid strategy.
    BMJ. 2021;375:n3149.
    >> Share

  141. RICHTERMAN A, Scott J, Cevik M
    Covid-19 vaccines, immunity, and boosters.
    BMJ. 2021;375:n3105.
    >> Share

  142. HAQUE Z
    Vaccine inequality may undermine the booster programme.
    BMJ. 2021;375:n3118.
    >> Share

  143. GELLAD WF
    Myocarditis after vaccination against covid-19.
    BMJ. 2021;375:n3090.
    >> Share

  144. HUSBY A, Hansen JV, Fosbol E, Thiesson EM, et al
    SARS-CoV-2 vaccination and myocarditis or myopericarditis: population based cohort study.
    BMJ. 2021;375:e068665.
    >> Share

  145. HOPSON C
    If the NHS falls short on boosters, it won't be for want of trying.
    BMJ. 2021;375:n3106.
    >> Share

  146. OSAMA T, Hodes S, Razai MS, Majeed A, et al
    Boosting the nation against covid-19: are the vaccination targets feasible?
    BMJ. 2021;375:n3094.
    >> Share

  147. BRUXVOORT KJ, Sy LS, Qian L, Ackerson BK, et al
    Effectiveness of mRNA-1273 against delta, mu, and other emerging variants of SARS-CoV-2: test negative case-control study.
    BMJ. 2021;375:e068848.
    >> Share

  148. IACOBUCCI G
    Covid-19: GPs are told to postpone routine care to focus on vaccine boosters in response to omicron.
    BMJ. 2021;375:n3083.
    >> Share

  149. SARELA A
    Condemning consensus is not helpful.
    BMJ. 2021;375:n3073.
    >> Share

  150. HASSAN F, London L, Gonsalves G
    Unequal global vaccine coverage is at the heart of the current covid-19 crisis.
    BMJ. 2021;375:n3074.
    >> Share

  151. KMIETOWICZ Z
    Covid-19: Monoclonal antibodies authorised in US as alternative to vaccines for certain groups.
    BMJ. 2021;375:n3064.
    >> Share

  152. SAUL H, Gursul D
    Stressing the personal benefits of the covid-19 vaccine might encourage more people to accept it.
    BMJ. 2021;375:n2923.
    >> Share

  153. MAHASE E
    Covid-19: Do vaccines work against omicron-and other questions answered.
    BMJ. 2021;375:n3062.
    >> Share

  154. WATERS SJ
    Mandatory covid-19 vaccination for healthcare workers: all employers are bound by health and safety laws to reduce risk.
    BMJ. 2021;375:n3039.
    >> Share

  155. PIZZO M
    Mandatory vaccination for healthcare workers: consequences of denying bodily autonomy.
    BMJ. 2021;375:n3041.
    >> Share

  156. TINARI S, Riva C
    Covid-19: Whatever happened to the Novavax vaccine?
    BMJ. 2021;375:n2965.
    >> Share

  157. MCCARTNEY M
    Bureaucracy has created a mess for Novavax volunteers like me.
    BMJ. 2021;375:n2995.
    >> Share

  158. MAHASE E
    Covid-19: "Mix and match" primary vaccines are safe and effective, study finds.
    BMJ. 2021;375:n3030.
    >> Share

  159. PORTER S
    Mandatory covid-19 vaccination for healthcare workers: vaccinated and unvaccinated people seem as likely to infect others.
    BMJ. 2021;375:n3027.
    >> Share

  160. WISE J
    Covid-19: Build on success of vaccination programme in reaching ethnic minority groups, report recommends.
    BMJ. 2021;375:n3003.
    >> Share

  161. MAHASE E
    Covid-19: Antibody boost after third dose varies greatly by vaccine, study finds.
    BMJ. 2021;375:n3011.
    >> Share

  162. AHMAD A, Haqmal M
    Strengthening routine polio vaccination in Afghanistan.
    BMJ. 2021;375:n2935.
    >> Share

  163. ZHANG Y, Quigley A, Wang Q, MacIntyre CR, et al
    Non-pharmaceutical interventions during the roll out of covid-19 vaccines.
    BMJ. 2021;375:n2314.
    >> Share

  164. AN Z, Wang F, Pan A, Yin Z, et al
    Vaccination strategy and challenges for consolidating successful containment of covid-19 with population immunity in China.
    BMJ. 2021;375:e066125.
    >> Share

  165. TU H, Hu K, Zhang M, Zhuang Y, et al
    Effectiveness of 14 day quarantine strategy: Chinese experience of prevention and control.
    BMJ. 2021;375:e066121.
    >> Share

    November 2021
  166. TORJESEN I
    Covid-19: Omicron may be more transmissible than other variants and partly resistant to existing vaccines, scientists fear.
    BMJ. 2021;375:n2943.
    >> Share

  167. RAMCHANDANI R, Kazatchkine M, Liu J, Sudan P, et al
    Vaccines, therapeutics, and diagnostics for covid-19: redesigning systems to improve pandemic response.
    BMJ. 2021;375:e067488.
    >> Share

  168. JUNG AS, Haldane V, Neill R, Wu S, et al
    National responses to covid-19: drivers, complexities, and uncertainties in the first year of the pandemic.
    BMJ. 2021;375:e068954.
    >> Share

  169. CLARK H, Sirleaf EJ
    Ending this pandemic and securing the future.
    BMJ. 2021;375:n2914.
    >> Share

  170. MAHASE E
    Covid-19: Vaccine uptake during pregnancy has increased but deprived areas lag behind, data show.
    BMJ. 2021;375:n2932.
    >> Share

  171. ARONSON JK
    When I use a word . . . . No jab, no job? A benefit:harm balance analysis.
    BMJ. 2021;375:n2934.
    >> Share

  172. YAMEY G, McDade KK, Brennan RJ, Abubakar A, et al
    Preventing pandemics in the world's most vulnerable settings.
    BMJ. 2021;375:n2897.
    >> Share

  173. ISRAEL A, Merzon E, Schaffer AA, Shenhar Y, et al
    Elapsed time since BNT162b2 vaccine and risk of SARS-CoV-2 infection: test negative design study.
    BMJ. 2021;375:e067873.
    >> Share

  174. EXTANCE A
    mRNA vaccines: hope beneath the hype.
    BMJ. 2021;375:n2744.
    >> Share

  175. MAHASE E
    Covid-19: What next for the Valneva vaccine?
    BMJ. 2021;375:n2839.
    >> Share

  176. IACOBUCCI G
    Covid-19 and pregnancy: vaccine hesitancy and how to overcome it.
    BMJ. 2021;375:n2862.
    >> Share

  177. ALTMANN D, Boyton R
    Covid-19 caseload in the UK-assessments and mitigations.
    BMJ. 2021;375:n2843.
    >> Share

  178. PUNTIS J
    Test and trace system continues to fail.
    BMJ. 2021;375:n2808.
    >> Share

  179. IACOBUCCI G
    Covid-19: England is preparing to offer annual booster vaccination, says NHS boss.
    BMJ. 2021;375:n2824.
    >> Share

  180. SRIVASTAVA K
    Fake covid vaccines boost the black market for counterfeit medicines.
    BMJ. 2021;375:n2754.
    >> Share

  181. MAHASE E
    Covid-19: Booster vaccine gives "significant increased protection" in over 50s.
    BMJ. 2021;375:n2814.
    >> Share

  182. TALIC S, Shah S, Wild H, Gasevic D, et al
    Effectiveness of public health measures in reducing the incidence of covid-19, SARS-CoV-2 transmission, and covid-19 mortality: systematic review and meta-analysis.
    BMJ. 2021;375:e068302.
    >> Share

  183. DYER O
    Covid-19: US doctor who called masks "dangerous" and vaccines a "human experiment" dies of coronavirus.
    BMJ. 2021;375:n2796.
    >> Share

  184. PATTERSON L
    Encouraging covid vaccine uptake and safe behaviours-an uphill struggle against government complacency.
    BMJ. 2021;375:n2773.
    >> Share

  185. DYER O
    Covid-19: Moderna seeks to exclude US government scientists from vaccine patents, despite public investment.
    BMJ. 2021;375:n2781.
    >> Share

  186. LOOI MK
    The world according to covid vaccine coverage.
    BMJ. 2021;375:n2732.
    >> Share

  187. RIMMER A
    Covid vaccination to be mandatory for NHS staff in England from spring 2022.
    BMJ. 2021;375:n2733.
    >> Share

  188. WISE J
    Covid-19: Pfizer vaccine provides 90% protection against infection in children aged 5-11, study finds.
    BMJ. 2021;375:n2746.
    >> Share

  189. IACOBUCCI G
    Covid-19: How is the UK's vaccine booster programme faring?
    BMJ. 2021;375:n2702.
    >> Share

  190. TORJESEN I
    HPV vaccine cut cervical cancer rates in England by 87.
    BMJ. 2021;375:n2689.
    >> Share

  191. TANNE JH
    Covid-19: Biden administration sets 4 January deadline to vaccinate most US workers.
    BMJ. 2021;375:n2708.
    >> Share

  192. TANNE JH
    Covid-19: US doctors begin administering vaccine to children aged 5-11.
    BMJ. 2021;375:n2693.
    >> Share

  193. SLEAT D, Innes K, Parker I
    Are vaccine passports and covid passes a valid alternative to lockdown?
    BMJ. 2021;375:n2571.
    >> Share

  194. SHEPHERD A
    Taliban lifts ban on polio vaccinations in Afghanistan.
    BMJ. 2021;375:n2656.
    >> Share

  195. THACKER PD
    Covid-19: Researcher blows the whistle on data integrity issues in Pfizer's vaccine trial.
    BMJ. 2021;375:n2635.
    >> Share

  196. SOKOL D
    Covid-19 vaccination should be mandatory for healthcare workers.
    BMJ. 2021;375:n2670.
    >> Share

  197. ENGLISH PMB
    Covid vaccine committee decisions: don't forget JCVI has little or no extra resources to do many times its usual work.
    BMJ. 2021;375:n2646.
    >> Share

    October 2021
  198. TORJESEN I
    Covid-19: One in four vaccinated people living in households with a covid-19 case become infected, study finds.
    BMJ. 2021;375:n2638.
    >> Share

  199. FEINMANN J
    Covid-19: global vaccine production is a mess and shortages are down to more than just hoarding.
    BMJ. 2021;375:n2375.
    >> Share

  200. DYER O
    Covid-19: US and China prepare for mass vaccination of children under 12.
    BMJ. 2021;375:n2631.
    >> Share

  201. MAHASE E
    Covid-19: Just a third of blood cancer patients had antibodies against delta variant after two vaccine doses, study finds.
    BMJ. 2021;375:n2623.
    >> Share

  202. TAYLOR L
    Covid-19: Protect healthcare workers with vaccines, urges WHO after 115 000 die worldwide.
    BMJ. 2021;375:n2592.
    >> Share

  203. CHRISTIE B
    Covid-19: Vaccines are highly effective in preventing deaths from delta variant, study indicates.
    BMJ. 2021;375:n2582.
    >> Share

  204. IACOBUCCI G
    The UK government's covid complacency shows lessons haven't been learned.
    BMJ. 2021;375:n2584.
    >> Share

  205. MAHASE E
    Covid-19: Valneva's vaccine produces stronger immune response than AstraZeneca's, company reports.
    BMJ. 2021;375:n2551.
    >> Share

  206. ABBAS-HANIF A, Modi N, Smith SK, Majeed A, et al
    Covid-19 treatments and vaccines must be evaluated in pregnancy.
    BMJ. 2021;375:n2377.
    >> Share

  207. PATERLINI M
    Covid-19: Sweden, Norway, and Finland suspend use of Moderna vaccine in young people "as a precaution".
    BMJ. 2021;375:n2477.
    >> Share

  208. MAHASE E
    Covid-19: Trial participants are offered approved vaccines so they can travel abroad.
    BMJ. 2021;375:n2474.
    >> Share

  209. WISE J
    WHO hails "historic day" as it recommends malaria vaccine.
    BMJ. 2021;375:n2455.
    >> Share

  210. MAHASE E
    Covid-19: Vaccine advisory committee must be more transparent about decisions, say researchers.
    BMJ. 2021;375:n2452.
    >> Share

  211. BOYTCHEV H
    Covid-19: Why the Balkans' vaccine rollout lags behind most of Europe.
    BMJ. 2021;375:n2412.
    >> Share

  212. WISE J
    Vaccinating against covid and flu at same time is safe, study shows.
    BMJ. 2021;375:n2411.
    >> Share

  213. PAVORD S, Hunt BJ, Horner D, Bewley S, et al
    Vaccine induced immune thrombocytopenia and thrombosis: summary of NICE guidance.
    BMJ. 2021;375:n2195.
    >> Share

  214. DOSHI P
    Covid-19: Spreading vaccine "misinformation" puts licence at risk, US boards tell physicians.
    BMJ. 2021;375:n2417.
    >> Share

    September 2021
  215. MAJEED A, Hodes S, Marks S
    Consent for covid-19 vaccination in children.
    BMJ. 2021;374:n2356.
    >> Share

  216. MAHASE E
    Covid-19: Fully vaccinated patients no longer need to test or isolate before elective procedures, hospitals are told.
    BMJ. 2021;374:n2383.
    >> Share

  217. DYER O
    Covid-19: New York's health workers agree to vaccinate as mandate bites.
    BMJ. 2021;374:n2390.
    >> Share

  218. MENDIS S
    Regional vaccine production is key to ensuring equity.
    BMJ. 2021;374:n2354.
    >> Share

  219. DYER O
    Covid-19: Rich countries' booster plans will impede global vaccination, experts say.
    BMJ. 2021;374:n2353.
    >> Share

  220. SCOTT J, Richterman A, Cevik M
    Covid-19 vaccination: evidence of waning immunity is overstated.
    BMJ. 2021;374:n2320.
    >> Share

  221. SAXENA S, Skirrow H, Bedford H, Wighton K, et al
    Covid-19 vaccines for teenagers: conversations and consent.
    BMJ. 2021;374:n2312.
    >> Share

  222. LIMB M
    Compulsory covid vaccination: Loss of care home workers puts beds and care at risk, warn unions and providers.
    BMJ. 2021;374:n2318.
    >> Share

  223. MOON S, Agarwal S, Becker A, Alonso Ruiz A, et al
    Embedding global access in development of future pandemic vaccines.
    BMJ. 2021;374:n2256.
    >> Share

  224. IACOBUCCI G
    Covid-19: How is vaccination affecting hospital admissions and deaths?
    BMJ. 2021;374:n2306.
    >> Share


  225. Risk prediction of covid-19 related death and hospital admission in adults after covid-19 vaccination: national prospective cohort study.
    BMJ. 2021;374:n2300.
    >> Share

  226. HIPPISLEY-COX J, Coupland CA, Mehta N, Keogh RH, et al
    Risk prediction of covid-19 related death and hospital admission in adults after covid-19 vaccination: national prospective cohort study.
    BMJ. 2021;374:n2244.
    >> Share

  227. SILBERNER J
    Covid-19: How Native Americans led the way in the US vaccination effort.
    BMJ. 2021;374:n2168.
    >> Share


  228. Vaccinating people who have had covid-19: why doesn't natural immunity count in the US?
    BMJ. 2021;374:n2272.
    >> Share

  229. EARL H
    Profiteering from vaccine inequity: nudge pharma towards "doing well by doing good".
    BMJ. 2021;374:n2255.
    >> Share

  230. MALE V
    Menstrual changes after covid-19 vaccination.
    BMJ. 2021;374:n2211.
    >> Share

  231. MUNRO C
    Covid-19: Boys are more at risk of myocarditis after vaccination than of hospital admission for covid.
    BMJ. 2021;374:n2251.
    >> Share

  232. IACOBUCCI G
    Covid-19: Vaccinating children will help end pandemic, says minister.
    BMJ. 2021;374:n2254.
    >> Share

  233. BLOCK J
    Vaccinating people who have had covid-19: why doesn't natural immunity count in the US?
    BMJ. 2021;374:n2101.
    >> Share

  234. DYER O
    Covid-19: US imposes mandatory vaccination on two thirds of workforce.
    BMJ. 2021;374:n2238.
    >> Share

  235. IACOBUCCI G
    Covid-19: Children aged 12-15 should be offered vaccine, say UK's chief medical officers.
    BMJ. 2021;374:n2248.
    >> Share

  236. CHRISTIE B
    Covid-19: Vaccine passports approved in Scotland despite criticism.
    BMJ. 2021;374:n2229.
    >> Share

  237. RIMMER A
    Covid-19: Government considers mandatory vaccination for healthcare staff in England.
    BMJ. 2021;374:n2222.
    >> Share

  238. DE BEER PAM, Van den Abbeele K
    Inviting adolescents aged 12-17 for covid-19 vaccination: the need for patience.
    BMJ. 2021;374:n2172.
    >> Share

  239. SALISBURY H
    Helen Salisbury: Blood bottles, vaccines, and freight.
    BMJ. 2021;374:n2184.
    >> Share


  240. Effectiveness of the CoronaVac vaccine in older adults during a gamma variant associated epidemic of covid-19 in Brazil: test negative case-control study.
    BMJ. 2021;374:n2091.
    >> Share

  241. IACOBUCCI G
    Covid-19: JCVI opts not to recommend universal vaccination of 12-15 year olds.
    BMJ. 2021;374:n2180.
    >> Share

  242. TORJESEN I
    Sixty seconds on . . . covid booster vaccines.
    BMJ. 2021;374:n2179.
    >> Share

  243. SILVER A
    Why Taiwan approved its own vaccine before phase III trials.
    BMJ. 2021;374:n2104.
    >> Share

  244. WISE J
    Covid-19: UK will offer third vaccine dose to severely immunosuppressed people.
    BMJ. 2021;374:n2160.
    >> Share

  245. LOOI MK
    Vaccine passports around the world.
    BMJ. 2021;374:n2142.
    >> Share

  246. PAGEL C
    Schools: a gaping hole in England's covid strategy.
    BMJ. 2021;374:n2115.
    >> Share

    August 2021
  247. DYER O
    Malaria: Combining vaccine with prophylaxis cuts child deaths by 73%, study finds.
    BMJ. 2021;374:n2137.
    >> Share


  248. How the world is (not) handling surplus doses and expiring vaccines.
    BMJ. 2021;374:n2127.
    >> Share

  249. KLUNGEL OH, Pottegard A
    Strengthening international surveillance of vaccine safety.
    BMJ. 2021;374:n1994.
    >> Share

  250. HIPPISLEY-COX J, Patone M, Mei XW, Saatci D, et al
    Risk of thrombocytopenia and thromboembolism after covid-19 vaccination and SARS-CoV-2 positive testing: self-controlled case series study.
    BMJ. 2021;374:n1931.
    >> Share

  251. FEINMANN J
    How the world is (not) handling surplus doses and expiring vaccines.
    BMJ. 2021;374:n2062.
    >> Share

  252. IACOBUCCI G
    Covid-19: Protection from two doses of vaccine wanes within six months, data suggest.
    BMJ. 2021;374:n2113.
    >> Share

  253. MUNRO C
    Covid-19: 40% of patients with weakened immune system mount lower response to vaccines.
    BMJ. 2021;374:n2098.
    >> Share

  254. TANNE JH
    Covid-19: FDA approves Pfizer-BioNTech vaccine in record time.
    BMJ. 2021;374:n2096.
    >> Share

  255. MAHASE E
    Covid-19 vaccines: GPs boost uptake by calling patients and teaming up with community groups.
    BMJ. 2021;374:n2093.
    >> Share

  256. WADVALLA BA
    How South Africa is dragging its vaccine rollout back from the brink.
    BMJ. 2021;374:n1949.
    >> Share

  257. IACOBUCCI G
    Covid-19: FDA set to grant full approval to Pfizer vaccine without public discussion of data.
    BMJ. 2021;374:n2086.
    >> Share

  258. RANZANI OT, Hitchings MDT, Dorion M, D'Agostini TL, et al
    Effectiveness of the CoronaVac vaccine in older adults during a gamma variant associated epidemic of covid-19 in Brazil: test negative case-control study.
    BMJ. 2021;374:n2015.
    >> Share

  259. MAHASE E
    Covid-19 booster vaccines: What we know and who's doing what.
    BMJ. 2021;374:n2082.
    >> Share

  260. MARCHETTI F, Tamburlini G
    Other good reasons for covid-19 vaccination in pre-adolescent and adolescent populations.
    BMJ. 2021;374:n2052.
    >> Share

  261. CHUNG H, He S, Nasreen S, Sundaram ME, et al
    Effectiveness of BNT162b2 and mRNA-1273 covid-19 vaccines against symptomatic SARS-CoV-2 infection and severe covid-19 outcomes in Ontario, Canada: test negative design study.
    BMJ. 2021;374:n1943.
    >> Share

  262. GRIFFIN S
    Covid-19: Fully vaccinated people can carry as much delta virus as unvaccinated people, data indicate.
    BMJ. 2021;374:n2074.
    >> Share

  263. CABEZAS C, Coma E, Mora-Fernandez N, Li X, et al
    Associations of BNT162b2 vaccination with SARS-CoV-2 infection and hospital admission and death with covid-19 in nursing homes and healthcare workers in Catalonia: prospective cohort study.
    BMJ. 2021;374:n1868.
    >> Share

  264. TAYLOR L
    Ivory Coast rolls out Ebola vaccine after first confirmed case since 1994.
    BMJ. 2021;374:n2047.
    >> Share

  265. SCHWEIGER M
    Intradermal covid-19 vaccination could solve supply problems.
    BMJ. 2021;374:n1980.
    >> Share

  266. TANNE JH
    Covid-19: Cases in children rise sharply in US as doctors call for vaccine approval.
    BMJ. 2021;374:n2030.
    >> Share

  267. MAHASE E
    Covid-19: Two vaccine doses are crucial for protection against delta, study finds.
    BMJ. 2021;374:n2029.
    >> Share

  268. HASSAN F, Yamey G, Abbasi K
    Profiteering from vaccine inequity: a crime against humanity?
    BMJ. 2021;374:n2027.
    >> Share

  269. SHEMTOB L, Ferris M, Asanati K, Majeed A, et al
    Vaccinating healthcare workers against covid-19.
    BMJ. 2021;374:n1975.
    >> Share

  270. BARANIUK C
    Covid-19: How effective are vaccines against the delta variant?
    BMJ. 2021;374:n1960.
    >> Share

  271. IACOBUCCI G
    Covid-19: Junior doctors write to young people to acknowledge vaccine concerns.
    BMJ. 2021;374:n1963.
    >> Share

  272. MAHASE E
    Covid-19: All 16 and 17 year olds in the UK to be offered first vaccine dose.
    BMJ. 2021;374:n1958.
    >> Share

  273. TAYLOR L
    Why Cuba developed its own covid vaccine-and what happened next.
    BMJ. 2021;374:n1912.
    >> Share

  274. PARKER M, Bedford H, Ussher M, Stead M, et al
    Should covid vaccination be mandatory for health and care staff?
    BMJ. 2021;374:n1903.
    >> Share

  275. MITTELMAN M
    Patient commentary: Protect patients like me-make covid vaccines mandatory for all eligible staff in care settings.
    BMJ. 2021;374:n1921.
    >> Share

  276. AHMED N
    Commentary: Mandatory covid vaccination blames individual care home workers for government failures.
    BMJ. 2021;374:n1902.
    >> Share

  277. ERFANI P, Binagwaho A, Jalloh MJ, Yunus M, et al
    Intellectual property waiver for covid-19 vaccines will advance global health equity.
    BMJ. 2021;374:n1837.
    >> Share

  278. DYER O
    Covid-19: Delta infections threaten herd immunity vaccine strategy.
    BMJ. 2021;374:n1933.
    >> Share

    July 2021
  279. MAHASE E
    Covid-19: Pfizer vaccine's efficacy declined from 96% to 84% four months after second dose, company reports.
    BMJ. 2021;374:n1920.
    >> Share

  280. WISE J
    Covid-19: NICE issues guidance on vaccine induced immune thrombocytopenia and thrombosis.
    BMJ. 2021;374:n1914.
    >> Share

  281. MAHASE E
    Covid-19: Countries dump vaccines as demand slumps and sharing proves difficult.
    BMJ. 2021;374:n1893.
    >> Share

  282. TANNE JH
    Covid-19: US public health officials urge FDA to decide on booster vaccines.
    BMJ. 2021;374:n1877.
    >> Share

  283. SAXENA S, Skirrow H, Wighton K
    Should the UK vaccinate children and adolescents against covid-19?
    BMJ. 2021;374:n1866.
    >> Share

  284. MAHASE E
    Covid-19: Vulnerable children aged 12-15 will be offered Pfizer vaccine, UK announces.
    BMJ. 2021;374:n1841.
    >> Share

  285. IACOBUCCI G
    Covid-19: Fully vaccinated NHS staff may not need to self-isolate.
    BMJ. 2021;374:n1830.
    >> Share

  286. TORJESEN I
    Covid-19: Vaccine centres operating at 30% capacity as young people stay away.
    BMJ. 2021;374:n1808.
    >> Share

  287. O'DOWD A
    Covid-19 vaccination: GPs ruled out of booster campaign at practice level.
    BMJ. 2021;374:n1811.
    >> Share

  288. WISE J
    Covid-19: France and Greece make vaccination mandatory for healthcare workers.
    BMJ. 2021;374:n1797.
    >> Share

  289. DYER O
    Covid-19: Regulators warn that rare Guillain-Barre cases may link to J&J and AstraZeneca vaccines.
    BMJ. 2021;374:n1786.
    >> Share

  290. TINARI S, Riva C
    Donuts, drugs, booze, and guns: what governments are offering people to take covid-19 vaccines.
    BMJ. 2021;374:n1737.
    >> Share

  291. DYER O
    Covid-19: Turkmenistan becomes first country to make vaccination mandatory for all adults.
    BMJ. 2021;374:n1766.
    >> Share

  292. TORJESEN I
    Covid-19: Free rapid testing may end once most adults are fully vaccinated.
    BMJ. 2021;374:n1760.
    >> Share

  293. WILKINSON D, Finlay I, Pollard AJ, Forsberg L, et al
    Should we delay covid-19 vaccination in children?
    BMJ. 2021;374:n1687.
    >> Share

  294. TANNE JH
    Covid-19: Biden renews vaccines push as cases and deaths rise among unvaccinated people.
    BMJ. 2021;374:n1742.
    >> Share

  295. WISE J
    Covid-19: Vaccines journal retracts controversial paper after editorial board members quit.
    BMJ. 2021;374:n1726.
    >> Share

  296. HAYES L, Pollock AM
    Mandatory covid-19 vaccination for care home workers.
    BMJ. 2021;374:n1684.
    >> Share

  297. TAYLOR L
    Covid-19: Vaccine corruption allegations spark protests across Brazil.
    BMJ. 2021;374:n1724.
    >> Share

  298. GREEN ST
    Recognising the value of "shared pain"-mandatory covid-19 vaccination should include all NHS workers.
    BMJ. 2021;374:n1668.
    >> Share

  299. GRIFFIN S
    Covid-19: Millions could be offered booster vaccinations from September.
    BMJ. 2021;374:n1686.
    >> Share

  300. MAHASE E
    Covid-19: Pfizer vaccine could provide lasting immunity, small study suggests.
    BMJ. 2021;374:n1675.
    >> Share

    June 2021
  301. RIMMER A
    Covid-19: GP staff have faced threats and abuse during vaccination programme, poll finds.
    BMJ. 2021;373:n1665.
    >> Share

  302. CROZIER A, Dunning J, Rajan S, Semple MG, et al
    Could expanding the covid-19 case definition improve the UK's pandemic response?
    BMJ. 2021;374:n1625.
    >> Share

  303. STOKEL-WALKER C
    Covid-19: The countries that have mandatory vaccination for health workers.
    BMJ. 2021;373:n1645.
    >> Share

  304. MAHASE E
    Covid-19: Third vaccine dose boosts immune response but may not be needed, say researchers.
    BMJ. 2021;373:n1659.
    >> Share

  305. EVANS NG, Berger ZD, Phelan AL, Silverman RD, et al
    Covid-19, equity, and inclusiveness.
    BMJ. 2021;373:n1631.
    >> Share

  306. TANNE JH
    Covid-19: US doctors suggest new ways to target vaccine hesitancy.
    BMJ. 2021;373:n1640.
    >> Share

  307. TEERAWATTANANON Y, Teo YY, Lim JFY, Hsu LY, et al
    Vaccinating undocumented migrants against covid-19.
    BMJ. 2021;373:n1608.
    >> Share

  308. WISE J
    Covid-19: Should we be worried about reports of myocarditis and pericarditis after mRNA vaccines?
    BMJ. 2021;373:n1635.
    >> Share

  309. RAMACHANDRAN R, Dhodapkar M, Ross JS, Schwartz JL, et al
    Future of covid-19 vaccine pricing: lessons from influenza.
    BMJ. 2021;373:n1467.
    >> Share

  310. EASTON GP
    Resisting the "righting reflex" in conversations about covid vaccine hesitancy.
    BMJ. 2021;373:n1566.
    >> Share

  311. HODES S, Majeed A
    Building a sustainable infrastructure for covid-19 vaccinations long term.
    BMJ. 2021;373:n1578.
    >> Share

  312. LO RE V 3RD, Klungel OH, Chan KA, Panozzo CA, et al
    Global covid-19 vaccine rollout and safety surveillance-how to keep pace.
    BMJ. 2021;373:n1416.
    >> Share

  313. TAYLOR L
    Covid-19: WHO pleads for vaccines as South American countries register record deaths.
    BMJ. 2021;373:n1587.
    >> Share

  314. WILKINSON E
    Covid-19 vaccine outreach: "local knowledge, contacts, and credibility really, really matter".
    BMJ. 2021;373:n1547.
    >> Share

  315. DYER C
    Covid-19: Vaccination to become mandatory for care home staff and could extend to NHS.
    BMJ. 2021;373:n1576.
    >> Share

  316. ABI-JAOUDE E
    Vaccinating children against SARS-CoV-2: maximise uptake among adults while prioritising the most vulnerable.
    BMJ. 2021;373:n1533.
    >> Share

  317. MAHASE E
    Covid-19: Delaying end of lockdown will allow more people to be vaccinated, UK government announces.
    BMJ. 2021;373:n1552.
    >> Share

  318. LOOI MK
    Covid-19: Extended emergency and Olympic concerns overshadow Japan's accelerated vaccine rollout.
    BMJ. 2021;373:n1546.
    >> Share

  319. DONALDSON C, Biosca O
    Covid-19: an economic perspective on vaccinating the world.
    BMJ. 2021;373:n1498.
    >> Share

  320. DYER O
    Covid-19: Vaccine doses expire in US as uptake falls by 68.
    BMJ. 2021;373:n1536.
    >> Share

  321. LI X, Ostropolets A, Makadia R, Shoaibi A, et al
    Characterising the background incidence rates of adverse events of special interest for covid-19 vaccines in eight countries: multinational network cohort study.
    BMJ. 2021;373:n1435.
    >> Share

  322. WISE J
    Covid-19: AstraZeneca vaccine linked with small risk of ITP, real world data show.
    BMJ. 2021;373:n1489.
    >> Share

  323. LLOYD-SHERLOCK P, Kandiyil NM, McKee M, Perianayagam A, et al
    Pandemic lessons from India: inappropriate prioritisation for vaccination.
    BMJ. 2021;373:n1464.
    >> Share

  324. MAHASE E
    Childhood vaccination: Access problems in UK began way before covid-19.
    BMJ. 2021;373:n1436.
    >> Share

  325. PALMER BS
    Covid-19 eradication: stopping transmission between countries.
    BMJ. 2021;373:n1425.
    >> Share

  326. MAHASE E
    Covid-19: Freedom won't last if UK doesn't share excess vaccine doses, aid agencies warn.
    BMJ. 2021;373:n1444.
    >> Share

  327. MAHASE E
    Covid-19: UK has highest vaccine confidence and Japan and South Korea the lowest, survey finds.
    BMJ. 2021;373:n1439.
    >> Share

  328. BLOCK J
    US college covid-19 vaccine mandates don't consider immunity or pregnancy, and may run foul of the law.
    BMJ. 2021;373:n1397.
    >> Share

    May 2021
  329. SHEPHERD A
    Protesters call for UK to back covid vaccine waiver.
    BMJ. 2021;373:n1388.
    >> Share

  330. KRISHTEL P, Malpani R
    Suspend intellectual property rights for covid-19 vaccines.
    BMJ. 2021;373:n1344.
    >> Share

  331. TORJESEN I
    Covid-19: Pfizer-BioNTech vaccine is "likely" responsible for deaths of some elderly patients, Norwegian review finds.
    BMJ. 2021;373:n1372.
    >> Share

  332. DYER O
    Covid-19: Variants are spreading in countries with low vaccination rates.
    BMJ. 2021;373:n1359.
    >> Share

  333. THACKER PD
    Covid-19: How independent were the US and British vaccine advisory committees?
    BMJ. 2021;373:n1283.
    >> Share


  334. Public health impact of delaying second dose of BNT162b2 or mRNA-1273 covid-19 vaccine: simulation agent based modeling study.
    BMJ. 2021;373:n1334.
    >> Share

  335. IACOBUCCI G
    Covid-19: Single vaccine dose is 33% effective against variant from India, data show.
    BMJ. 2021;373:n1346.
    >> Share

  336. IACOBUCCI G
    Covid-19: Are high rates of B.1.617.2 linked to vaccine hesitancy?
    BMJ. 2021;373:n1345.
    >> Share

  337. CARTWRIGHT AC, Tompkins M, Boncey J, Hastie C, et al
    Patient information on covid-19 vaccines-a vaccine centre lottery.
    BMJ. 2021;373:n1310.
    >> Share

  338. IACOBUCCI G
    Covid-19: Local councils initiate surge vaccination to tackle B.1.617.2 variant.
    BMJ. 2021;373:n1361.
    >> Share

  339. RAZAI MS, Chaudhry UAR, Doerholt K, Bauld L, et al
    Covid-19 vaccination hesitancy.
    BMJ. 2021;373:n1138.
    >> Share

  340. MAHASE E
    Covid-19: Advocates urge India's prime minister to remove barriers to vaccine production and access.
    BMJ. 2021;373:n1297.
    >> Share

  341. DOSHI P
    Covid-19 vaccines: In the rush for regulatory approval, do we need more data?
    BMJ. 2021;373:n1244.
    >> Share

  342. IACOBUCCI G
    Covid-19: Most UK adults had antibodies after one dose of AstraZeneca or Pfizer vaccine, data suggest.
    BMJ. 2021;373:n1274.
    >> Share

  343. WISE J
    Covid-19: Second vaccine doses expedited in areas of England where new variant is high.
    BMJ. 2021;373:n1266.
    >> Share

  344. GONSALVES G, Yamey G
    The covid-19 vaccine patent waiver: a crucial step towards a "people's vaccine".
    BMJ. 2021;373:n1249.
    >> Share

  345. LAVINE JS, Bjornstad O, Antia R
    Vaccinating children against SARS-CoV-2.
    BMJ. 2021;373:n1197.
    >> Share

  346. LISEWSKI AM
    Effectiveness of England's initial vaccine roll out.
    BMJ. 2021;373:n1201.
    >> Share

  347. LOPEZ BERNAL J, Andrews N, Gower C, Robertson C, et al
    Effectiveness of the Pfizer-BioNTech and Oxford-AstraZeneca vaccines on covid-19 related symptoms, hospital admissions, and mortality in older adults in England: test negative case-control study.
    BMJ. 2021;373:n1088.
    >> Share

  348. ROMERO-BRUFAU S, Chopra A, Ryu AJ, Gel E, et al
    Public health impact of delaying second dose of BNT162b2 or mRNA-1273 covid-19 vaccine: simulation agent based modeling study.
    BMJ. 2021;373:n1087.
    >> Share

  349. IACOBUCCI G
    Covid-19: Fever, chills, and aches more common when AstraZeneca and Pfizer vaccines are mixed, early data show.
    BMJ. 2021;373:n1216.
    >> Share

  350. KMIETOWICZ Z
    Covid-19: Caution urged while lockdown eases in England because of vaccine success.
    BMJ. 2021;373:n1203.
    >> Share

  351. TANNE JH
    Covid-19: FDA authorises Pfizer vaccine for children 12-15.
    BMJ. 2021;373:n1204.
    >> Share

  352. IACOBUCCI G
    Covid-19: How will a waiver on vaccine patents affect global supply?
    BMJ. 2021;373:n1182.
    >> Share

  353. MAHASE E
    Covid-19: UK offers under 40s alternative to AstraZeneca vaccine to boost confidence.
    BMJ. 2021;373:n1185.
    >> Share


  354. Covid-19: Sputnik vaccine rockets, thanks to Lancet boost.
    BMJ. 2021;373:n1174.
    >> Share

  355. VAN TULLEKEN C
    Covid-19: Sputnik vaccine rockets, thanks to Lancet boost.
    BMJ. 2021;373:n1108.
    >> Share

  356. TANNE JH
    Covid-19: Biden aims for 70% of Americans to have at least one vaccination by 4 July.
    BMJ. 2021;373:n1155.
    >> Share

  357. PERERA R, Fletcher J
    Thromboembolism and the Oxford-AstraZeneca vaccine.
    BMJ. 2021;373:n1159.
    >> Share

  358. POTTEGARD A, Lund LC, Karlstad O, Dahl J, et al
    Arterial events, venous thromboembolism, thrombocytopenia, and bleeding after vaccination with Oxford-AstraZeneca ChAdOx1-S in Denmark and Norway: population based cohort study.
    BMJ. 2021;373:n1114.
    >> Share

  359. IACOBUCCI G
    Covid-19: Two doses of Pfizer vaccine are "highly effective" against infection, hospital admission, and death, study finds.
    BMJ. 2021;373:n1164.
    >> Share

  360. MAHASE E
    Covid-19: Vaccines will be tested against variants of concern after pound29m funding boost from UK government.
    BMJ. 2021;373:n1163.
    >> Share

  361. SHEPHERD A
    Covid-19: Photograph collection records historic vaccine rollout.
    BMJ. 2021;373:n1125.
    >> Share

  362. DYER C
    Covid-19: Students overlooked for vaccine in favour of family members at Dublin hospital.
    BMJ. 2021;373:n1136.
    >> Share

    April 2021
  363. MAHASE E
    Covid-19: Most people admitted to hospital after vaccination were infected before immunity could develop, research shows.
    BMJ. 2021;373:n1127.
    >> Share

  364. MAHASE E
    Covid-19: Booster vaccine to be rolled out in autumn as UK secures 60m more Pfizer doses.
    BMJ. 2021;373:n1116.
    >> Share

  365. TANNE JH
    Covid-19: US relaxes rules on mask wearing for fully vaccinated people.
    BMJ. 2021;373:n1115.
    >> Share

  366. MAHASE E
    Covid-19: One dose of vaccine cuts risk of passing on infection by as much as 50%, research shows.
    BMJ. 2021;373:n1112.
    >> Share

  367. TANNE JH
    Covid-19: US authorises Johnson and Johnson vaccine again, ending pause in rollout.
    BMJ. 2021;373:n1079.
    >> Share

  368. IACOBUCCI G
    Covid-19: Government will consider call to allow GPs to vaccinate in their own surgeries.
    BMJ. 2021;373:n1084.
    >> Share

  369. MAHASE E
    Malaria vaccine becomes first to achieve 75% efficacy goal in trial of children.
    BMJ. 2021;373:n1078.
    >> Share

  370. IACOBUCCI G
    Covid-19: Infections fell by 65% after first dose of AstraZeneca or Pfizer vaccine, data show.
    BMJ. 2021;373:n1068.
    >> Share

  371. WISE J
    Covid-19: Is the UK heading towards mandatory vaccination of healthcare workers?
    BMJ. 2021;373:n1056.
    >> Share

  372. MAHASE E
    Covid-19: Unusual blood clots are "very rare side effect" of Janssen vaccine, says EMA.
    BMJ. 2021;373:n1046.
    >> Share

  373. DYER O
    Covid-19: Canada relaxes age limits on AstraZeneca vaccine as Ontario cases surge.
    BMJ. 2021;373:n1053.
    >> Share

  374. THIAGARAJAN K
    What do we know about India's Covaxin vaccine?
    BMJ. 2021;373:n997.
    >> Share

  375. TAYLOR L
    Covid-19: Spike in cases in Chile is blamed on people mixing after first vaccine shot.
    BMJ. 2021;373:n1023.
    >> Share

  376. MAHASE E
    Covid-19: Pregnant women should be offered Pfizer or Moderna vaccine, says UK advisory committee.
    BMJ. 2021;373:n1013.
    >> Share

  377. DYER C
    Covid-19: Irish GP who refused to vaccinate patients is suspended.
    BMJ. 2021;373:n987.
    >> Share

  378. TORJESEN I
    Covid-19: Risk of cerebral blood clots from disease is 10 times that from vaccination, study finds.
    BMJ. 2021;373:n1005.
    >> Share

  379. DYER O
    Covid-19: US reports low rate of new infections in people already vaccinated.
    BMJ. 2021;373:n1000.
    >> Share

  380. MAHASE E
    Covid-19: Single dose of Pfizer or AstraZeneca vaccine produces strong antibody response in over 80s.
    BMJ. 2021;373:n979.
    >> Share

  381. HUNTER PR
    Thrombosis after covid-19 vaccination.
    BMJ. 2021;373:n958.
    >> Share

  382. WISE J
    Covid-19: How AstraZeneca lost the vaccine PR war.
    BMJ. 2021;373:n921.
    >> Share

  383. CHATTERJEE P
    Covid-19: India authorises Sputnik V vaccine as cases soar to more than 180 000 a day.
    BMJ. 2021;373:n978.
    >> Share

  384. MAHASE E
    Covid-19: Moderna and Novavax vaccines to be tested in mixing vaccines trial.
    BMJ. 2021;373:n971.
    >> Share

  385. MAHASE E
    Covid-19: EU investigates four reports of blood clots after Janssen vaccine.
    BMJ. 2021;373:n961.
    >> Share

  386. MAHASE E
    Covid-19: US suspends Johnson and Johnson vaccine rollout over blood clots.
    BMJ. 2021;373:n970.
    >> Share

  387. DYER O
    Covid-19: Chinese vaccines may need changes to improve efficacy, admits official.
    BMJ. 2021;373:n969.
    >> Share

  388. RIMMER A
    Covid-19: Colleges publish guidance after patients attend emergency departments with vaccine concerns.
    BMJ. 2021;373:n960.
    >> Share

  389. WISE J
    Covid-19: Rare immune response may cause clots after AstraZeneca vaccine, say researchers.
    BMJ. 2021;373:n954.
    >> Share

  390. BIGNARDI G
    Reporting of AstraZeneca studies may have caused vaccine reservations.
    BMJ. 2021;373:n937.
    >> Share

  391. BEST J
    How the JCVI sets who gets a covid-19 vaccine and when.
    BMJ. 2021;373:n820.
    >> Share

  392. BARANIUK C
    What do we know about China's covid-19 vaccines?
    BMJ. 2021;373:n912.
    >> Share

  393. KAMPMANN B, Jack SM
    Covid-19 vaccines save lives.
    BMJ. 2021;373:n886.
    >> Share

  394. MAHASE E
    AstraZeneca vaccine: Blood clots are "extremely rare" and benefits outweigh risks, regulators conclude.
    BMJ. 2021;373:n931.
    >> Share

  395. SIMPSON PL, Levy M, Butler T
    Incarcerated people should be prioritised for covid-19 vaccination.
    BMJ. 2021;373:n859.
    >> Share

  396. RIMMER A
    Covid-19: Certifying status for "vaccine passports" must not increase GPs' workload, says Royal College.
    BMJ. 2021;373:n919.
    >> Share

  397. WOOD A, Denholm R, Hollings S, Cooper J, et al
    Linked electronic health records for research on a nationwide cohort of more than 54 million people in England: data resource.
    BMJ. 2021;373:n826.
    >> Share

  398. PATERLINI M
    Covid-19: Italy makes vaccination mandatory for healthcare workers.
    BMJ. 2021;373:n905.
    >> Share

  399. TANNE JH
    Covid-19: All Johnson and Johnson vaccine in use is safe, says US regulator.
    BMJ. 2021;373:n897.
    >> Share

  400. OSAMA T, Razai MS, Majeed A
    Covid-19 vaccine passports: access, equity, and ethics.
    BMJ. 2021;373:n861.
    >> Share

  401. MUGHAL F
    Covid-19 vaccination during Ramadan.
    BMJ. 2021;373:n862.
    >> Share

  402. MAHASE E
    Covid-19: Pfizer reports 100% vaccine efficacy in children aged 12 to 15.
    BMJ. 2021;373:n881.
    >> Share

  403. DYER O
    Covid-19: Moderna and Pfizer vaccines prevent infections as well as symptoms, CDC study finds.
    BMJ. 2021;373:n888.
    >> Share

  404. DYER O
    Covid-19: EMA defends AstraZeneca vaccine as Germany and Canada halt rollouts.
    BMJ. 2021;373:n883.
    >> Share

    March 2021
  405. BHUYAN A
    Covid-19: India sees new spike in cases despite vaccine rollout.
    BMJ. 2021;372:n854.
    >> Share

  406. TANNE JH
    Covid-19: US cases rise while vaccinations increase.
    BMJ. 2021;372:n850.
    >> Share

  407. KMIETOWICZ Z
    Sixty seconds on . . . vaccine bribes.
    BMJ. 2021;372:n841.
    >> Share

  408. RIMMER A
    Do doctors have to have the covid-19 vaccine?
    BMJ. 2021;372:n810.
    >> Share

  409. MAHASE E
    Covid vaccine: Prioritise over 16s living with immunosuppressed adults, says JCVI.
    BMJ. 2021;372:n852.
    >> Share

  410. WATSON R
    Covid-19 vaccines: Europe tightens export criteria in bid to secure more doses.
    BMJ. 2021;372:n838.
    >> Share

  411. MOBERLY T
    Covid-19: Vaccine hesitancy fell after vaccination programme started.
    BMJ. 2021;372:n837.
    >> Share

  412. DARBY AC, Hiscox JA
    Covid-19: variants and vaccination.
    BMJ. 2021;372:n771.
    >> Share

  413. KMIETOWICZ Z
    Covid-19: Officials query data from AstraZeneca's US vaccine trial.
    BMJ. 2021;372:n807.
    >> Share

  414. GRIFFIN S
    Covid-19: AstraZeneca vaccine prevents 79% of symptomatic disease and 100% of severe disease, US study finds.
    BMJ. 2021;372:n793.
    >> Share

  415. MAHASE E
    Covid-19: AstraZeneca vaccine is not linked to increased risk of blood clots, finds European Medicine Agency.
    BMJ. 2021;372:n774.
    >> Share

  416. GOLDSTEIN A
    Failure to achieve global vaccine equity will have dire consequences.
    BMJ. 2021;372:n712.
    >> Share

  417. DAY M
    Covid-19: Stronger warnings are needed to curb socialising after vaccination, say doctors.
    BMJ. 2021;372:n783.
    >> Share

  418. BARANIUK C
    Covid-19: What do we know about Sputnik V and other Russian vaccines?
    BMJ. 2021;372:n743.
    >> Share

  419. TORJESEN I
    Covid-19 vaccine shortages: what is the cause and what are the implications?
    BMJ. 2021;372:n781.
    >> Share

  420. PIMENTA D, Yates C, Pagel C, Gurdasani D, et al
    Delaying the second dose of covid-19 vaccines.
    BMJ. 2021;372:n710.
    >> Share

  421. SHEPHERD A
    Covid-19: Chile joins top five countries in world vaccination league.
    BMJ. 2021;372:n718.
    >> Share

  422. WATSON R
    Covid-19: EU looks to speed up vaccine rollout.
    BMJ. 2021;372:n730.
    >> Share

  423. MAHASE E
    Covid vaccine could be rolled out to children by autumn.
    BMJ. 2021;372:n723.
    >> Share

  424. MAHASE E
    Covid-19: WHO says rollout of AstraZeneca vaccine should continue, as Europe divides over safety.
    BMJ. 2021;372:n728.
    >> Share

  425. IACOBUCCI G
    Covid-19: NHS will keep offering vaccinations to those who refuse, says minister.
    BMJ. 2021;372:n702.
    >> Share

  426. WISE J
    Covid-19: European countries suspend use of Oxford-AstraZeneca vaccine after reports of blood clots.
    BMJ. 2021;372:n699.
    >> Share

  427. SAHOTA R
    How easy will it really be to replicate the success of the covid-19 vaccine with neglected infectious diseases?
    BMJ. 2021;372:n678.
    >> Share

  428. DYER O
    Covid-19: US Catholics split after bishops' conference recommends against Johnson and Johnson vaccine.
    BMJ. 2021;372:n666.
    >> Share

  429. DAGLI M
    Covid mutations: honest approach needed from politicians and scientists on pandemic outlook.
    BMJ. 2021;372:n656.
    >> Share

  430. MAHASE E
    Covid-19: Booster dose will be needed in autumn to avoid winter surge, says government adviser.
    BMJ. 2021;372:n664.
    >> Share

  431. MAHASE E
    A vaccine against malaria: five minutes with . . . Richard Bucala.
    BMJ. 2021;372:n651.
    >> Share

  432. CHIOLERO A, Cullati S, Santschi V
    Primary healthcare for a long term and sustainable vaccination strategy.
    BMJ. 2021;372:n650.
    >> Share

  433. GARDINER T, Abraham S, Clymer O, Rao M, et al
    Racial and ethnic health disparities in healthcare settings.
    BMJ. 2021;372:n605.
    >> Share

  434. IYER AA, Millum J, Grady C, Wendler D, et al
    Avoiding exploitation in multinational covid-19 vaccine trials.
    BMJ. 2021;372:n541.
    >> Share

  435. SHEPHERD A
    Portraits of the people who made vaccines possible.
    BMJ. 2021;372:n595.
    >> Share

  436. RIMMER A
    Covid-19: 237m vaccine doses to be distributed worldwide over next three months.
    BMJ. 2021;372:n631.
    >> Share

  437. MAHASE E
    Covid-19: Schedule breast screening before vaccine or 4 to 6 weeks after to avoid false positives, says guidance.
    BMJ. 2021;372:n617.
    >> Share

  438. BOYTCHEV H
    Covid-19: Germany struggles with slow uptake of Oxford AstraZeneca vaccine.
    BMJ. 2021;372:n619.
    >> Share

  439. IACOBUCCI G
    Covid-19: Single dose of Pfizer and Oxford vaccines cuts risk of hospital admission by 80% in over 80s, data suggest.
    BMJ. 2021;372:n612.
    >> Share

  440. MAHASE E
    Covid-19: Where are we on vaccines and variants?
    BMJ. 2021;372:n597.
    >> Share

  441. SALISBURY H
    Helen Salisbury: Stepping back from vaccination priorities and focusing on minimising the risk of exposure.
    BMJ. 2021;372:n591.
    >> Share

    February 2021

  442. Jeremy Farrar: Make vaccine available to other countries as soon as our most vulnerable people have received it.
    BMJ. 2021;372:n581.
    >> Share

  443. RAZAI MS, Osama T, McKechnie DGJ, Majeed A, et al
    Covid-19 vaccine hesitancy among ethnic minority groups.
    BMJ. 2021;372:n513.
    >> Share

  444. IACOBUCCI G
    Covid-19: NHS England pledges extra funding to local areas to reduce vaccine inequalities.
    BMJ. 2021;372:n580.
    >> Share

  445. BASNYAT B, Qamar FN, Rupali P, Ahmed T, et al
    Enteric fever.
    BMJ. 2021;372:n437.
    >> Share

  446. WISE J
    Covid-19: One in seven people in England have antibodies from infection or vaccination, finds study.
    BMJ. 2021;372:n561.
    >> Share

  447. WISE J
    Covid-19: Pfizer BioNTech vaccine reduced cases by 94% in Israel, shows peer reviewed study.
    BMJ. 2021;372:n567.
    >> Share

  448. MULLER-SEDGWICK U
    Optimal dosing interval for covid-19 vaccines: we need clinical trial evidence and to consider past infection.
    BMJ. 2021;372:n522.
    >> Share

  449. MAHASE E
    Covid-19: All adults on learning disability register should be prioritised for vaccination, says advisory committee.
    BMJ. 2021;372:n547.
    >> Share

  450. IACOBUCCI G
    Covid-19: GPs could get extra funding to boost vaccine uptake in hard-to-reach groups.
    BMJ. 2021;372:n548.
    >> Share

  451. BHOPAL SS, Absoud M
    Vaccinating children to prevent long covid? More caution is needed in interpreting current epidemiological data.
    BMJ. 2021;372:n520.
    >> Share

  452. SILBERNER J
    Behind the scenes of the Pfizer BioNTech covid-19 vaccine trial.
    BMJ. 2021;372:n271.
    >> Share

  453. IACOBUCCI G, Mahase E
    Covid-19: Vaccine success drives England's lockdown exit.
    BMJ. 2021;372:n528.
    >> Share

  454. CUNNINGHAM AL, McIntyre P, Subbarao K, Booy R, et al
    Vaccines for older adults.
    BMJ. 2021;372:n188.
    >> Share

  455. BHOPAL R
    Defer vaccination of people who have had covid-19.
    BMJ. 2021;372:n465.
    >> Share

  456. LIMB M
    Covid-19: Plans to share vaccines aren't enough, says charity.
    BMJ. 2021;372:n516.
    >> Share

  457. TORJESEN I
    Covid-19: First doses of vaccines in Scotland led to a substantial fall in hospital admissions.
    BMJ. 2021;372:n523.
    >> Share

  458. LOOI MK
    Jeremy Farrar: Make vaccine available to other countries as soon as our most vulnerable people have received it.
    BMJ. 2021;372:n459.
    >> Share

  459. WISE J
    Covid-19: Is vaccination roll out reducing cases and deaths in the UK?
    BMJ. 2021;372:n506.
    >> Share

  460. IACOBUCCI G
    Covid-19: No evidence that vaccines can affect fertility, says new guidance.
    BMJ. 2021;372:n509.
    >> Share

  461. GRIFFIN S
    Covid-19: Ethnicity vaccination gap narrows in England, but concerns remain.
    BMJ. 2021;372:n505.
    >> Share

  462. IACOBUCCI G
    Covid-19: GPs opt to prioritise all patients with learning disabilities for vaccination.
    BMJ. 2021;372:n510.
    >> Share

  463. BARANIUK C
    Covid-19: How the UK vaccine rollout delivered success, so far.
    BMJ. 2021;372:n421.
    >> Share

  464. IACOBUCCI G
    Flu vaccination: Lansley reforms caused London to fall behind in uptake, report finds.
    BMJ. 2021;372:n480.
    >> Share

  465. MILLS MC, Sivela J
    Should spreading anti-vaccine misinformation be criminalised?
    BMJ. 2021;372:n272.
    >> Share

  466. IACOBUCCI G
    Covid:19: Ethnic minority health staff are less likely to take up vaccine, early data show.
    BMJ. 2021;372:n460.
    >> Share

  467. BOYTCHEV H
    Why did a German newspaper insist the Oxford AstraZeneca vaccine was inefficacious for older people-without evidence?
    BMJ. 2021;372:n414.
    >> Share

  468. BELL KJL, Glasziou P, Stanaway F, Bossuyt P, et al
    Equity and evidence during vaccine rollout: stepped wedge cluster randomised trials could help.
    BMJ. 2021;372:n435.
    >> Share

  469. BARANIUK C
    Covid-19: People with mild asthma won't get early vaccination.
    BMJ. 2021;372:n430.
    >> Share

  470. DAGLI M
    Covid-19: No convincing evidence for increasing the vaccine dosing interval.
    BMJ. 2021;372:n401.
    >> Share

  471. YAMEY G
    Developing vaccines for neglected and emerging infectious diseases.
    BMJ. 2021;372:n373.
    >> Share

  472. TORJESEN I
    Covid-19: First UK vaccine safety data are "reassuring," says regulator.
    BMJ. 2021;372:n363.
    >> Share

  473. MAHASE E
    Covid-19: South Africa pauses use of Oxford vaccine after study casts doubt on efficacy against variant.
    BMJ. 2021;372:n372.
    >> Share

  474. O'DOWD A
    Covid-19: Black people over 80 in England are half as likely as white people to have been vaccinated.
    BMJ. 2021;372:n357.
    >> Share

  475. BARANIUK C
    How to vaccinate the world against covid-19.
    BMJ. 2021;372:n211.
    >> Share

  476. MAHASE E
    Covid-19: Israel sees new infections plummet following vaccinations.
    BMJ. 2021;372:n338.
    >> Share

  477. WISE J
    Covid-19: New data on Oxford AstraZeneca vaccine backs 12 week dosing interval.
    BMJ. 2021;372:n326.
    >> Share

  478. FEINMANN J
    Why aren't covid-19 vaccines being manufactured in standard prefilled syringes?
    BMJ. 2021;372:n263.
    >> Share

  479. LLOYD-SHERLOCK P, Muljono P, Ebrahim S
    Ageism in Indonesia's national covid-19 vaccination programme.
    BMJ. 2021;372:n299.
    >> Share

  480. GOH S
    Covid-19 vaccination: the dangers of "values" imperialism.
    BMJ. 2021;372:n302.
    >> Share

  481. MAHASE E
    Covid-19: Russian vaccine efficacy is 91.6%, show phase III trial results.
    BMJ. 2021;372:n309.
    >> Share

  482. WISE J
    Covid-19: People who have had infection might only need one dose of mRNA vaccine.
    BMJ. 2021;372:n308.
    >> Share

  483. BARER D
    Covid-19: volunteers cannot be outsourced.
    BMJ. 2021;372:n259.
    >> Share

  484. TORJESEN I
    Covid-19: AstraZeneca vaccine is approved in EU with no upper age limit.
    BMJ. 2021;372:n295.
    >> Share

  485. EATON L
    Covid-19: WHO warns against "vaccine nationalism" or face further virus mutations.
    BMJ. 2021;372:n292.
    >> Share

  486. MAHASE E
    Covid-19: Novavax vaccine efficacy is 86% against UK variant and 60% against South African variant.
    BMJ. 2021;372:n296.
    >> Share

    January 2021
  487. DYER O
    Covid-19: Countries are learning what others paid for vaccines.
    BMJ. 2021;372:n281.
    >> Share

  488. YOON D, Lee JH, Lee H, Shin JY, et al
    Association between human papillomavirus vaccination and serious adverse events in South Korean adolescent girls: nationwide cohort study.
    BMJ. 2021;372:m4931.
    >> Share

  489. THIAGARAJAN K
    Covid-19: India is at centre of global vaccine manufacturing, but opacity threatens public trust.
    BMJ. 2021;372:n196.
    >> Share

  490. NABAVI N
    Covid-19 vaccination for medical students: the grey area.
    BMJ. 2021;372:n261.
    >> Share

  491. IACOBUCCI G
    Covid-19: NHS must tackle vaccine lies to improve uptake among ethnic minorities, says Stevens.
    BMJ. 2021;372:n242.
    >> Share

  492. TANNE JH
    Covid-19: Biden buys 200 million doses of vaccines to tackle supply shortages across US.
    BMJ. 2021;372:n246.
    >> Share

  493. WATERMAN LZ
    Cultural competence in vaccine rollout: migrants would face difficulties accessing covid-19 vaccines.
    BMJ. 2021;372:n220.
    >> Share

  494. SALISBURY H
    Helen Salisbury: Pedalling vaccines door to door.
    BMJ. 2021;372:n221.
    >> Share

  495. PATTEN D, Green A, Bown D, Russell C, et al
    Covid-19: Use social media to maximise vaccine confidence and uptake.
    BMJ. 2021;372:n225.
    >> Share

  496. MAHASE E
    Covid-19: Medical community split over vaccine interval policy as WHO recommends six weeks.
    BMJ. 2021;372:n226.
    >> Share

  497. LIMB M
    Covid-19: What is happening with the vaccine rollout?
    BMJ. 2021;372:n213.
    >> Share

  498. MAHASE E
    Covid-19: Reports from Israel suggest one dose of Pfizer vaccine could be less effective than expected.
    BMJ. 2021;372:n217.
    >> Share

  499. RIMMER A
    Covid-19: Three quarters of UK doctors have had first vaccine dose, BMA survey finds.
    BMJ. 2021;372:n190.
    >> Share

  500. WARDLE C, Singerman E
    Too little, too late: social media companies' failure to tackle vaccine misinformation poses a real threat.
    BMJ. 2021;372:n26.
    >> Share

  501. SALISBURY H
    Helen Salisbury: Keeping vaccinations local.
    BMJ. 2021;372:n145.
    >> Share

  502. MAHASE E
    Covid-19: Assess the effects of extending Pfizer vaccine dosing interval, expert urges.
    BMJ. 2021;372:n162.
    >> Share

  503. TORJESEN I
    Covid-19: Doctors in Norway told to assess severely frail patients for vaccination.
    BMJ. 2021;372:n167.
    >> Share

  504. TANNE JH
    Covid-19: Biden calls for science, vaccines, and masks.
    BMJ. 2021;372:n150.
    >> Share

  505. GLOVER RE, Urquhart R, Lukawska J, Blumenthal KG, et al
    Vaccinating against covid-19 in people who report allergies.
    BMJ. 2021;372:n120.
    >> Share

  506. TORJESEN I
    Covid-19: Norway investigates 23 deaths in frail elderly patients after vaccination.
    BMJ. 2021;372:n149.
    >> Share

  507. BMJ IC
    India: Doctors call for investigation into allegations of ethical abuse in covid-19 vaccine trial.
    BMJ. 2021;372:n131.
    >> Share

  508. SHEPHERD A
    Under starters orders: NHS's biggest ever vaccine drive.
    BMJ. 2021;372:n87.
    >> Share

  509. IACOBUCCI G
    Covid-19: All doctors should be offered first vaccine dose by mid-February, government says.
    BMJ. 2021;372:n88.
    >> Share

  510. MATHEW R
    Rammya Mathew: We should use this moment of crisis to make significant gains in vaccine uptake.
    BMJ. 2021;372:n66.
    >> Share

  511. MAHASE E
    How the Oxford-AstraZeneca covid-19 vaccine was made.
    BMJ. 2021;372:n86.
    >> Share

  512. MAHASE E
    Covid-19: UK approves Moderna vaccine to be given as two doses 28 days apart.
    BMJ. 2021;372:n74.
    >> Share

  513. IACOBUCCI G
    Covid-19 vaccinations in the community: five minutes with . . . Anuj Patel.
    BMJ. 2021;372:n79.
    >> Share

  514. LIMB M
    Covid-19: Data on vaccination rollout and its effects are vital to gauge progress, say scientists.
    BMJ. 2021;372:n76.
    >> Share

  515. RIMMER A
    Covid-19: Breastfeeding women can have vaccine after guidance turnaround.
    BMJ. 2021;372:n64.
    >> Share

  516. IACOBUCCI G
    Covid-19: GPs can limit routine work to focus on vaccination, says NHS England.
    BMJ. 2021;372:n67.
    >> Share

  517. KMIETOWICZ Z
    Covid-19: Health and social care staff must be vaccinated now, says BMA.
    BMJ. 2021;372:n60.
    >> Share


  518. Covid-19: Indian health officials defend approval of vaccine.
    BMJ. 2021;372:n52.
    >> Share

  519. IACOBUCCI G
    Covid-19 vaccine: GPs should decide whether to honour second dose appointments, says minister.
    BMJ. 2021;372:n46.
    >> Share

  520. TANNE JH
    Covid-19: US cases surge but vaccine distribution is slow.
    BMJ. 2021;372:n42.
    >> Share

  521. IACOBUCCI G, Mahase E
    Covid-19 vaccination: What's the evidence for extending the dosing interval?
    BMJ. 2021;372:n18.
    >> Share

  522. HERZOG LM, Norheim OF, Emanuel EJ, McCoy MS, et al
    Covax must go beyond proportional allocation of covid vaccines to ensure fair and equitable access.
    BMJ. 2021;372:m4853.
    >> Share

  523. HARE H, Womersley K
    Why were breastfeeding women in the UK denied the covid-19 vaccine?
    BMJ. 2021;372:n4.
    >> Share

  524. RIMMER A
    Covid-19: Health secretary vows to reduce bureaucracy faced by vaccination volunteers.
    BMJ. 2021;372:n13.
    >> Share

  525. MAHASE E
    Covid-19: Vaccine brands can be mixed in "extremely rare occasions," says Public Health England.
    BMJ. 2021;372:n12.
    >> Share

  526. SALISBURY H
    Helen Salisbury: Don't squander patients' trust in the vaccine rollout.
    BMJ. 2021;372:n3.
    >> Share

    December 2020
  527. MAHASE E
    Covid-19: Order to reschedule and delay second vaccine dose is "totally unfair," says BMA.
    BMJ. 2020;371:m4978.
    >> Share

  528. MAHASE E
    Covid-19: UK approves Oxford vaccine as cases of new variant surge.
    BMJ. 2020;371:m4968.
    >> Share

  529. DAY M
    Covid-19: Italian doctors are disciplined for anti-vaccination propaganda.
    BMJ. 2020;371:m4962.
    >> Share

  530. RIMMER A
    Covid-19: Doctors must be vaccinated without delay, says BMA.
    BMJ. 2020;371:m4964.
    >> Share

  531. LENZER J
    Covid-19: Should vaccine trials be unblinded?
    BMJ. 2020;371:m4956.
    >> Share

  532. MAHASE E
    Covid-19: Expedite vaccination or deaths will surge, researchers warn.
    BMJ. 2020;371:m4958.
    >> Share

  533. SKEGG D, Pearce N
    Unwarranted optimism about vaccine efficacy.
    BMJ. 2020;371:m4918.
    >> Share

  534. BAKER MG, Wilson N, Blakely T
    Elimination could be the optimal response strategy for covid-19 and other emerging pandemic diseases.
    BMJ. 2020;371:m4907.
    >> Share

  535. SEWELL HF, Agius RM, Kendrick D, Stewart M, et al
    Covid-19 vaccines: delivering protective immunity.
    BMJ. 2020;371:m4838.
    >> Share

  536. WANG W, Wu Q, Yang J, Dong K, et al
    Global, regional, and national estimates of target population sizes for covid-19 vaccination: descriptive study.
    BMJ. 2020;371:m4704.
    >> Share

  537. SCHWARTZ JL
    Equitable global access to coronavirus disease 2019 vaccines.
    BMJ. 2020;371:m4735.
    >> Share

  538. SO AD, Woo J
    Reserving coronavirus disease 2019 vaccines for global access: cross sectional analysis.
    BMJ. 2020;371:m4750.
    >> Share

  539. MAHASE E
    Covid-19: Logistical problems frustrate GPs ready to deliver vaccine in England.
    BMJ. 2020;371:m4849.
    >> Share

  540. TANNE JH
    Covid-19: Pfizer-BioNTech vaccine is rolled out in US.
    BMJ. 2020;371:m4836.
    >> Share

  541. DYER O
    Covid-19: Many poor countries will see almost no vaccine next year, aid groups warn.
    BMJ. 2020;371:m4809.
    >> Share

  542. TANNE JH
    Covid-19: FDA panel votes to approve Pfizer BioNTech vaccine.
    BMJ. 2020;371:m4799.
    >> Share

  543. MAHASE E
    Covid-19: Pfizer vaccine efficacy was 52% after first dose and 95% after second dose, paper shows.
    BMJ. 2020;371:m4826.
    >> Share

  544. DYER C
    Covid-19: Adults with learning disabilities should have priority access to vaccination, say lawyers.
    BMJ. 2020;371:m4824.
    >> Share

  545. MAHASE E
    Covid-19: People with history of significant allergic reactions should not receive Pfizer vaccine, says regulator.
    BMJ. 2020;371:m4780.
    >> Share

  546. MAHASE E
    Vaccinating the UK: how the covid vaccine was approved, and other questions answered.
    BMJ. 2020;371:m4759.
    >> Share

  547. MAHASE E
    Covid-19: Oxford vaccine could be 59% effective against asymptomatic infections, analysis shows.
    BMJ. 2020;371:m4777.
    >> Share

  548. JAYASOORIYA S, Mitchell C, Balen J, Darton TC, et al
    Seasonal influenza programme expansion.
    BMJ. 2020;371:m4713.
    >> Share

  549. DYER O
    White House demands to know how UK approved vaccine before FDA.
    BMJ. 2020;371:m4725.
    >> Share


  550. Claims and counterclaims over alleged adverse reaction in covid-19 vaccine in India.
    BMJ. 2020;371:m4734.
    >> Share

  551. MAHASE E
    Covid-19: Moderna applies for US and EU approval as vaccine trial reports 94.1% efficacy.
    BMJ. 2020;371:m4709.
    >> Share

  552. MAHASE E
    Covid-19: UK approves Pfizer and BioNTech vaccine with rollout due to start next week.
    BMJ. 2020;371:m4714.
    >> Share

    November 2020
  553. MAJEED A, Molokhia M
    Vaccinating the UK against covid-19.
    BMJ. 2020;371:m4654.
    >> Share

  554. MAHASE E
    Covid-19: UK government asks regulator to assess Oxford vaccine as questions are raised over interim data.
    BMJ. 2020;371:m4670.
    >> Share

  555. KAR P
    Partha Kar: Delivering covid vaccine-a team effort.
    BMJ. 2020;371:m4598.
    >> Share

  556. APPLEBY J
    Will covid-19 vaccines be cost effective-and does it matter?
    BMJ. 2020;371:m4491.
    >> Share

  557. MAHASE E
    Covid-19: What do we know about the late stage vaccine candidates?
    BMJ. 2020;371:m4576.
    >> Share

  558. DUNCAN H
    Covid-19 vaccine: we are sleepwalking into a massive prospective cohort study.
    BMJ. 2020;371:m4568.
    >> Share

  559. IACOBUCCI G
    Covid vaccine: GPs need more clarity on logistics and planning, say leaders.
    BMJ. 2020;371:m4555.
    >> Share

  560. MAHASE E
    Covid-19: Oxford vaccine is up to 90% effective, interim analysis indicates.
    BMJ. 2020;371:m4564.
    >> Share

  561. MAHASE E
    Covid-19: Pfizer and BioNTech submit vaccine for US authorisation.
    BMJ. 2020;371:m4552.
    >> Share

  562. TORJESEN I
    Covid-19: Third candidate vaccine will be tested in UK.
    BMJ. 2020;371:m4451.
    >> Share

  563. GRIFFIN S
    Covid-19: Governments should demand transparency on vaccine deals, says MSF.
    BMJ. 2020;371:m4430.
    >> Share

  564. IACOBUCCI G
    Covid-19: GPs to get pound12.58 per dose to deliver vaccine from December.
    BMJ. 2020;371:m4354.
    >> Share

  565. MCPARTLIN SO, Morrison J, Rohrig A, Weijer C, et al
    Covid-19 vaccines: Should we allow human challenge studies to infect healthy volunteers with SARS-CoV-2?
    BMJ. 2020;371:m4258.
    >> Share

  566. MAHASE E
    Covid-19: Vaccine candidate may be more than 90% effective, interim results indicate.
    BMJ. 2020;371:m4347.
    >> Share

  567. DYER O
    Covid-19: Denmark to kill 17 million minks over mutation that could undermine vaccine effort.
    BMJ. 2020;371:m4338.
    >> Share

  568. IACOBUCCI G
    Covid-19: GPs are told to be ready to deliver vaccine from next month.
    BMJ. 2020;371:m4291.
    >> Share

    October 2020
  569. DYER O
    South Korea to continue flu vaccinations after 25 deaths trigger calls for a pause.
    BMJ. 2020;371:m4116.
    >> Share

  570. MAHASE E
    Covid-19: Vaccine trials need more transparency to enable scrutiny and earn public trust, say experts.
    BMJ. 2020;371:m4042.
    >> Share

  571. MAHASE E
    Covid-19: Human challenge studies will see people purposefully infected with virus.
    BMJ. 2020;371:m4101.
    >> Share

  572. DOSHI P
    Will covid-19 vaccines save lives? Current trials aren't designed to tell us.
    BMJ. 2020;371:m4037.
    >> Share

  573. DOSHI P
    Covid-19 vaccine trial protocols released.
    BMJ. 2020;371:m4058.
    >> Share

  574. MAHASE E
    Midwives and paramedics can deliver flu and covid vaccines after new laws come into force.
    BMJ. 2020;371:m4044.
    >> Share

  575. MAHASE E
    Covid-19: Johnson and Johnson vaccine trial is paused because of unexplained illness in participant.
    BMJ. 2020;371:m3967.
    >> Share

  576. DYER O
    Covid-19: FDA defies Trump to publish rigorous vaccine development guidelines.
    BMJ. 2020;371:m3918.
    >> Share

  577. PAYNE N
    Covid-19 elimination: consider population level effects of vaccine.
    BMJ. 2020;371:m3889.
    >> Share

  578. SCHMIDT H, Pathak P, Sonmez T, Unver MU, et al
    Covid-19: how to prioritize worse-off populations in allocating safe and effective vaccines.
    BMJ. 2020;371:m3795.
    >> Share

  579. VAN DER WESTHUIZEN HM, Kotze K, Tonkin-Crine S, Gobat N, et al
    Authors' reply to Kolstoe and Hanna and colleagues.
    BMJ. 2020;371:m3799.
    >> Share

  580. MAHASE E
    Covid-19: Vaccine roll out could take a year and will require difficult prioritisation decisions.
    BMJ. 2020;371:m3846.
    >> Share

    September 2020
  581. KOLSTOE SE
    Covid-19: public messaging on vaccination must heed warnings from confused face mask messaging.
    BMJ. 2020;370:m3775.
    >> Share

  582. DYER C
    Covid-19: Government poised to amend regulations to allow use of unlicensed vaccine.
    BMJ. 2020;370:m3757.
    >> Share

  583. DYER O
    Covid-19: FDA plans strict vaccine approval criteria, angering Trump.
    BMJ. 2020;370:m3741.
    >> Share

  584. LYON JO
    Flu vaccination programme: could medical students be the answer?
    BMJ. 2020;370:m3698.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016